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Abstract
PC3 (pheochromocytoma celI-3) is an immediate early
gene isolated as sequence induced In the rat PCI2 cell
line during neuronal differentiation by nerve growth
factor (NGF). PC3, which is expressed in vWo in the
neuroblast when it ceases proliferating and
differentiates into a neuron, has partial homology with
two antiproliferative genes, BTGI and Tob. Here we
report that overexpression of PC3 in NIH3T3 and PCI2
cells leads to marked inhibition of cell proliferation. In
stable NIH3T3 clones expressing PC3, the transition
from G1 to S phase was impaired, whereas the
retinoblastoma (RB) protein was detected as multiple
isoforms of Mr 105,0001 15,000 flndicative of a
hyperphosphorylated state) only in low-density
cultures. Such findings are consistent with a condition
of growth inhibition. Thus, PC3 might be a negative
regulator of cell proliferation, possibly acting as a
transducer of factors influencing cell growth and/or
differentiation, such as NGF, by a RB-dependent
pathway. This is the first evidence of a NGF-inducible
immediate early gene displaying antiproliferative
activity.
Introduction
NGF3 is able to induce the differentiation of chromaffin cells
of the adrenal medulla and the PCi 2 cell line (derived from a
rat chromaffin-cell tumor) into sympathetic neurons (1). Sev-
eral genes are induced immediately after NGF stimulation,
pertaining to the category of lEGs, whose transcription is
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induced transiently. Such lEGs are also induced by mito-
genic growth factors, and some of them are proto-onco-
genes, i.e. , c-myc, c-fos, and c-jun (2, 3). Gene targeting has
indicated that these genes apparently are not required for the
growth of the animal until the early-mid-gestation period, but
they are necessary for the growth and function of some
specific cell types, i.e. , fibroblasts for c-jun (4) and bone and
placenta for c-fos (5, 6). In general, these proto-oncogenes
seem to be inhibitors of cell differentiation (reviewed in Ref.
7) and promoters of G1 progression (8, 9), behaving on the
whole as proliferation activators of specific tissues with rap-
idly dividing cells, under the control of mitogenic growth
factors.
Thus, because NGF leads PCi 2 cells to exit from the cell
cycle to attain differentiation (1 0), the induction of proto-
oncogenes seems contradictory. A possible explanation is
that the final decision for the cell to exit or remain in the cell
cycle is reached by an interplay between different NGF-
induced signals, either mitogenic (such as the above proto-
oncogenes) or antimitogenic, and also according to the state
of the cell, as suggested by growing knowledge of the cell
cycle regulatory network (1 1). However, thus far, the exist-
ence of any such antimitogenic lEG responsible for NGF-
dependent cell cycle arrest has not been verified.
In this context, the lEG PC3, isolated by us between
genes activated at the onset of neuronal differentiation in
PC12 cells by NGF (12) and by the Herschman group as
tetradecanoylphorbol acetate-induced sequence from
mouse NIH3T3 fibroblast cells (TIS21 ; Ref. 1 3), presents
features somewhat different from those of other lEGs. We
found that PC3 is expressed during neurogenesis with a
localization peculiar among lEGs as well as neural genes.
In fact, PC3 expression is restricted in space and time to
areas where the last neuroblast proliferation occurs, i.e. , is
coincident with the gradient of neuronal birth along the
germinal zone of the neural tube, both in the brain and
spinal cord regions, whereas no expression is detectable
in the surrounding mantle zone, where the postmitotic
neuron migrates (14). This observation, together with the
fact that the PC3 protein shares a partial degree of ho-
mology with two novel proteins endowed with antiprolif-
erative activity in NIH3T3 cells, BTG1 and Tob (60 and
40% homology, respectively; see Refs. 1 5 and 1 6), led us
to hypothesize that PC3 might exert a negative control of
proliferation, acting in vivo within a defined time-window
(i.e. , at the moment when the cell is committed to differ-
entiation; see also Ref. 14). In the study presented here,
we show that PC3 expression, obtained by sense PC3
cDNA transfection of NIH3T3 and PC12 cells, leads to an
inhibition of proliferation in parallel with the disappearance
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Fig. 1 . NGF-dependent expression of the PC3 protein in PCi 2 cells. A,
comparison of the PC3 protein r5S]methionine-Iabeled in vitro and from
PC12 cultures, immunoprecipitated by A3H polyclonal antibody. Rabbit
reticulocyte lysates were programmed with 0.5 g of PC3 RNA tran-
scribed with T3 RNA polymerase. The translation product was directly
loaded on the 15% SDS-polyacrylamide gel (Lane 1) or immunoprecipi-
tated with pre-immune serum (Lane 2) and antibody A3H (Lane 3). Lanes
4 and 5, immunoprecipitates from PC12 cells (untreated or treated for 1 h
with NGF). B, time course of the induction in PC12 cells of PC3 protein
synthesis by NGF. About 2 x 106 cells in 35-mm plates preincubated in
medium without methionine for 1 h were exposed to [5S]methionine for
1 .5 h and then harvested. Before harvesting, NGF was added to the
cultures for the time indicated (h). An aliquot of the whole lysate was
immunoprecipitated with the pre-immune serum (P1) or A3H antibody. The
immune complexes were loaded on a 12% SDS-polyacrylamide gel. The
molecular weight standards are indicated.
of hyperphosphorylated forms of pRB, suggesting that
PC3 might have a role in cell cycle regulation.
Results
Expression of the PC3 Protein. The PC3 cDNA predicts an
open reading frame of 158 amino acid residues, with a cal-
culated molecular mass of 17,731 kDa (1 2). To detect the
PC3 protein, we raised a polyclonal antibody (A3H) against a
bacterial fusion protein containing the PC3 protein. This was
obtained by cloning the complete coding region of PC3
cDNA in frame with a polyhistidine-tagged peptide encoded
by the pRSETA vector (see “Materials and Methods”). A
protein of the predicted relative molecular mass was de-
tected by immunoprecipitation with the A3H antibody of the
in vitro-translated PC3 cDNA and the cellular PC3 protein
from PCi 2 cells induced by NGF for 1 h (Fig. 1A). This would
indicate that the cellular PC3 protein does not undergo post-
translational modifications affecting the protein size, at least
in PCi 2 cells. This molecular mass seems to be the same as
that of the mouse homologue of PC3, TIS21 (1 3), as ox-
pected from a comparison of protein sequences (97.5%
homologous). The expression of PC3 protein in PC12 cells,
labeled for 90 mm with [35S]methionine and exposed to NGF
for increasing lengths of time, showed a peak 1 h after NGF
addition, followed by a rapid and permanent decrease within
2 h after NGF addition (Fig. 1B). This kinetic is coincident with
that observed for mRNA induction by NGF (12).
Cell Cycle-dependent Induction of PC3 by Serum and
NGF. A common feature of NGF-inducible lEGs, such as
c-fos, c-myc, c-jun, and Krox-24 (also known as NGFI-A,
TIS8, and Zif268), is the activation of their transcription by
serum during G0 to G1 transition (17-20). Also BTG1, an
antiproliferative gene related to PC3, is induced by serum in
NIH3T3 cells (1 5). Therefore, we sought to assess the pos-
sibility of a cell cycle-dependent expression of PC3. We
found that PC3 mRNA expression in cells arrested in G0 by
serum starvation, either NIH3T3 (Fig. 2A, 0 h) or PC12 cells
(Fig. 2C, 0 h), was equivalent to the expression observed in
nonsynchronized exponentially growing cultures, i.e. , unde-
tectable in NIH3T3 cells and relatively low in PCi 2 cells (Fig.
2, A and C, Lane C). When these synchronized cultures were
stimulated by serum to enter and progress through the cell
cycle as shown by the flow cytometry analysis (Fig. 2, B and
E), PC3 mRNA levels increased considerably and transiently
in NIH3T3 cells (Fig. 24), whereas a barely detectable in-
crease was seen in PCi 2 cells (Fig. 2C). In NIH3T3 cells, a
rapid decrease ensued within 6 h after serum addition, re-
turning to the undetectable level of G0-arrested and asyn-
chronously growing cultures (Fig. 2A). Clearly, serum in-
duced the expression of PC3 mRNA in NIH3T3 cells,
whereas the induction was scarcely detectable in PCi 2 cells,
even within shorter periods after serum addition (Fig. 2C and
data not shown).
When NGF was added to P012 cells stimulated by serum
to reenter the cell cycle, the resulting induction of PC3 mRNA
was maximal in G0 and the initial G1 (Fig. 2D, 0 and 3 h after
serum addition) and at the peak of the second G1 (Fig. 2, D
and E, 60 h), with similar levels. A lower level of induction of
PC3 mRNA by NGF was also seen 72 h after serum addition,
i.e. , at the onset of the second S phase, whereas it was
virtually absent at the first S phase (24 h after serum addi-
tion). The most plausible explanation for this difference is a
reduced homogeneity in cellular response during the second
cycle progression, consequent to the reduced synchroniza-
tion of the cell cultures (in this regard, in Fig. 2E, the G1:S
ratio of the first and second S phase, 24 and 72 h after serum
addition, should be compared). As a whole, our data indicate
that the induction of PC3 expression by NGF occurs in G0
and during the initial period of the G1 phase, rather than
during the late period.
Exogenous PC3 Overexpression Inhibits Cell Cycle
Progression, with a Delay in G1/S Transition. To verify
directly if PC3 is able to inhibit cell proliferation, we overex-
pressed PC3 in NIH3T3 cells. To this end, we used a retro-
viral vector containing a neomycin resistance marker, pBABE
Neo, in which the complete coding region of PC3 cDNA was
cloned (pBABE Neo-PC3). NIH3T3 cultures were infected
with the virus and selected by neomicin resistance. Five
independent clones expressing exogenous PC3 mRNA as
determined by RT-PCR were chosen for further character-
ization (Fig. 3, A and B). In general, positive clones were
obtained with a frequency of 10-1 5%. The retroviral PC3
transcript expressed in these clones was translated into pro-
tein detectable by immunoprecipitation (with the expected
mass of about 18 kDa; Fig. 3C) and immunofluorescence
staining (Fig. 3D). The exogenous PC3 protein seems to be
cytoplasmic, in agreement with data by Varnum et a!. (21),
although a nuclear localization of lesser evidence cannot be
excluded (Fig. 3D). In control clones Vi and V2, obtained
from NIH3T3 cells infected with the virus carrying no insert,
the endogenous PC3 protein was almost undetectable, as
expected (Fig. 3, C and D; see Refs. 1 3 and 21). Then, we
determined the growth curve of the five PC3-expressing
clones and control clones Vi and V2 as well as that of
NIH3T3 parental cells by measuring the number of viable
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Fig. 2. Cell cycle-dependent
induction of PC3 mRNA by se-
rum and NGF. NIH3T3 cells (1 x
1 05/60-mm plate) were synchro-
nized by serum starvation and
collected after the addition of
1 0% FS for the indicated times
for parallel analysis of RNA 1ev-
els by Northern blot (A; 5 g
RNA/sample) and DNA content
by flow cytometry to determine
the cell cycle profile (B, see
“Material and Methods” for de-
tails). Lane C in A contains RNA
from exponentially growing cul-
tures. The same analysis for
RNA levels (C) and DNA content
(E) was performed on PCi 2 cell
cultures (2 x 1 05/60-mm plate)
synchronized by serum starva-
tion and collected after the ad-
dition of 5% bovine serum and
5% horse serum for the mdi-
cated times. Cultures in D were
as in C except that they were
exposed to NGF (100 ng/ml) for
1 h before harvesting. C and D,
Lanes C and C+ contained RNA
from exponentially growing cul-
tures that were untreated or
treated with NGF (100 ng/ml for
1 h), respectively. Probes used
had equivalent specific activity
in all blots (about 1 x 106
dpm/ng for a total of about 60 x
106 dpm/7 ml), and exposure
times for autoradiographs were
the same (24 h for glyceralde-
hyde-3-phosphate dehydrogen-
ase and 48 h for the other
probes). The histone H4 expres-
sion was used as an independ-
ent observation of the S-phase
period.
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floating and adherent cells at different time points (Fig. 3E,
see “Materials and Methods”). In general, clones overex-
pressing P03 showed a significantly reduced proliferation
rate during the exponential phase, and a plateau in growth
was reached at or before confluence. The same cultures
overexpressing PC3 resumed growth when replated at low
density, although at a division rate lower than that of the
control cells (data not shown). Furthermore, the inhibition of
growth observed was not a consequence of reduced cell
viability because the ratio between dead and viable cells was
equivalent in control and PC3-expressing clones (data not
shown). Further evidence in this direction was obtained by
morphological evaluation of apoptosis using the DNA-spe-
cific stain H33258 as described (22). In fact, the nuclei of
PC3-expressing cell clones were normal, with uncondensed
chromatin dispersed over the whole nucleus. Fig. 4 shows a
representative field from clone 57.
BrdU incorporation, measured in cultures of clones Si and
V2 (plated as duplicate samples of the growth curve of Fig.
3E), indicated a significant inhibition of DNA synthesis in
clone 51 (e.g. , at day 3, mean ± SEM percent values of
incorporation in clone Si were 40.3 ± 1 .1 , whereas those for
clone V2 were 97.4 ± 0.5; data not shown).
As a complementary approach to assess the inhibition
of proliferation by PC3, we employed the colony formation
assay, a technique widely used to evaluate the inhibition of
proliferation by genes such as RB (23). The assay was
performed in NIH3T3 and PC12 cells. The resulting num-
ber of G418-resistant colonies was significantly lower in
NIH3T3 and PC12 cells transfected with the pBABE Neo-
PC3 expression construct, compared to cultures trans-
fected with the pBABE Neo vector without the insert or
containing PC3 oriented in antisense direction (Table 1,
experiments 1-3; Fig. 5; see “Materials and Methods”).
Furthermore, we sought to rule out the possibility of dif-
ferences in proliferation as a consequence of aspecific
actions (e.g. , toxic) by the exogenous PC3 mRNA. There-
fore, we transfected NIH3T3 cells with a pBABE Neo-PC3
expression construct bearing a nonsense mutation in the
ATG codon (pBABE Neo-PC3/P- ; see “Materials and
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Fig. 3. Inhibition of proliferation in NIH3T3 cell clones stably overexpressing PC3. A, equal amounts of RT-PCR products amplified from NIH3T3 clones
stably infected by a virus carrying PC3 (Si, 52, 54, 57 and 512) or without PC3 (V2) were electrophoresed, blotted on filter, and hybridized to PC3 and
f3-actin probes. RT+ and RT- , products of coamplification performed in parallel on two aliquots of each RNA starting sample preincubated with AT or not
preincubated with AT, respectively, to verify the absence of DNA contaminations. Ci and C2, control amplifications with pBABE Neo-PC3 or f3-actin cDNA
as templates. B, relative levels of exogenous PC3 RNA calculated from densities of Southern blot (A) as ratios of PC3/f3-actin PCR products, assuming the
ratio of sample Si = 1 00 [relative density = sample density x actin density sample Si x 100/actin density sample x sample Si density]. C,
immunoprecipitates with A3H antibody from whole lysates ofcell clones labeled with 0.1 mCVmI [5S]methionine (in 35-mm plates)for 90 mm. An additional
control clone (Vi) obtained by infection with the virus carrying no insert was analyzed. D, immunofluorescence staining of cells from Si and V2 clones. The
antigen was revealed by FITC staining after incubation with A3H antibody. Bar, 60 Am. E, proliferation rates of cell clones overexpressing PC3 (Si, 52, 54,
57 and 512) or without expression (Vi and V2) and of parental NIH3T3 cells. Equal numbers of cells were plated at day 0 (6 x 10” cells in duplicate 35-mm
plates). Shown at each time point is the number of viable cells (means ± SEM) of the two control or five PC3-expressing independent clones. Starting data
for analysis were the mean values of each duplicate determination. Parental NIH3T3 cell values represent the means of duplicate determinations (see also
“Material and Methods”). a (P < 0.05), ** (P < 0.01), or *** (P < 0.001) versus the corresponding value of vector-infected clones (Student’s t test).
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Methods”), producing an RNA differing essentially only for
the inability of being translated, and found that the number
of resulting G41 8-resistant colonies was not lower than in
NIH3T3 cell cultures transfected in parallel with the same
amount of pBABE Neo construct (Table 1 , experiments
4-6). This indicates that the effect on proliferation (seen as
inhibition of colony formation) is consequent only to ex-
pression of the PC3 protein.
We further investigated whether the impairment of prolif-
eration by PC3 was specific to a defined stage of cell cycle
progression. To this end, we analyzed by flow cytometry the
kinetics of cell cycle reentry in cultures of Si , 54, and V2
NIH3T3 clones, made quiescent by serum starvation and
stimulated to reenter the cell cycle by serum addition. We
observed that clones expressing PC3, with respect to the
control clone, presented a higher percentage of cells in
G/G1 at all times analyzed, with a significant difference 24 h
after serum addition (Fig. 6). This latter time corresponded to
the entry of the synchronized cultures into S phase (Figs. 6
and 2, A and B). Thus, overexpression of PC3 significantly
impairs cell cycle progression from GO/Gi to S phase. Cell
division was inhibited but not totally arrested, consistent with
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Fig. 4. Nuclear morphology of
NIH3T3 cells stably expressing
PC3. Immunofluorescence
staining of cells from S7 (A) and
vi control clone (C); right, the
corresponding field with fluores-
cent H33258-stained nuclei (B
and D). Bar, 35 .tm.
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Table i Analysis by colony formation assay of the effects of PC3 expression on NIH3T3 and PCi2 cell growth
- - ----- Growth suppression by PC3
Transfected cells No. of G41 8-resistant colonies (experiment no.)
Transfected DNA -------------- _______  
1 2 3 4 5 6
NIH3T3 pBABE Neo-PC3 13 1 10 15 12 12
pBABE Neo 58 25 82 71 103 91
pBABE Neo-PC3AS 52 53 95 - - -
pBABE Neo-PC3/P- - - - 74 101 107
PC12 pBABENeo-PC3 192 4 18 - - -
pBABE Nec 1 155 251 83 - - -
a Assays were carried out as described in Fig. 5 and in “Materials and Methods.”
the previous observation that clones expressing PC3 cul-
tured in conditions stimulating cell growth (i.e. , plating at low
density) do not cease to divide. As a whole, these experi-
ments indicate that PC3 negatively affects the proliferation
rate of both NIH3T3 and PCi 2 cells.
PC3 Overexpression Is Associated Preferentially to the
Hypophosphorylated pRB Isoform. pRB is a key growth-
suppressor protein whose activity is regulated by phospho-
rylation (for a review, see Ref. 24). In cultures growing expo-
nentially and asynchronously, pRB is present mainly in a
hyperphosphorylated state, whereas it is hypophosphory-
lated in conditions limiting growth (i.e. , leading to predomi-
nance of GO/Gi phase), such as serum deprivation or high
cell density (25-27). Hyperphosphorylated pRB can typically
be detected as multiplets of Mr 1 05,000-i i 5,000, whereas
the hypophosphorylated species can typically be detected
as a single band of about M, 105,000 (25, 26). Thus, we
sought to assess whether pRB expression or its isoforms
were modified by overexpressing PC3. To this end, we an-
alyzed the expression pattern of pRB in control and P03-
expressing clones at different times after plating, in correla-
tion with the cell density (Fig. 7). We observed that the
pattern of multiple bands, consistent with pRB being in the
hyperphosphorylated state, was detectable in clones Si and
S4 only at an early time point (day 1 , corresponding to a cell
density of about 8 x i 0 cells/cm2; see Fig. 7 legend), unlike
control clones Vi and V2, in which multiplets could be de-
tected clearly until day 3 (corresponding to a density of about
20 x i  cells/cm2; see Fig. 7 legend). At day 3, both Vi and
V2 control clones and Si and 54 clones were not yet con-
fluent, having a density comparable to that seen at the cor-
responding time point of the growth curve (Fig. 3E). At day 5,
control clones reached confluence at a density of about 70 x
i o cells/cm2, and this was associated with the disappear-
ance of forms corresponding to hyperphosphorylated pRB.
Thus, in P03-expressing cells, the timing of the appear-
ance of growth inhibition (day 3, i4 x i03 cells/cm2 versus
20 x 1 o cells/cm2 in control clones) was correlated with the
detection of the unphosphorylated pRB singlet species.
Discussion
Induction of PC3 by Serum and NGF. We have shown in
this report that overexpression ofthe P03 protein inhibits cell
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4 Unpublished observations.
5 Unpublished observations.
6 D. Guardavaccaro and F. Tirone, unpublished observations.
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Fig. 5. Inhibition of proliferation by PC3 in NIH3T3 and PC12 cells ob-
served by colony formation assay. Cell cultures (in 60-mm plates) were
transfected with the indicated plasmids. After 48 h, cell cultures were
trypsinized, diluted into 90-mm plates (1:150 for NIH3T3 cells and i :40 for
PC12 cells), and cultured in medium containing G4i8. The cultures were
fixed and stained with Giemsa solution. The experiment shown is one of
three reported in Table 1.
proliferation. The expression of PC3 mRNA is induced by
serum when quiescent cells reenter the cell cycle and by
NGF in the G0 and G1 phases. The strong induction by serum
in NIH3T3 cells, as well as that observed previously in
NIH3T3 cells by 12-O-tetradecanoylphorbol-i 3-acetate and
in PCi 2 cells by the proliferative EGF (i 2, 1 3), seems some-
what contradictory for a gene induced by a differentiative
and antiproliferative factor such as NGF (i 0). Activation by
serum and 1 2-O-tetradecanoylphorbol-i 3-acetate in
NIH3T3 cells and EGF in PCi2 cells is common to all NGF-
inducible lEGs; nonetheless, the conflict seems more rele-
vant in the case of P03, in consideration of its antiprolifera-
tive effects. However, recent data indicate that this conflict
might be only apparent. It has been suggested that in PCi 2
cells, the difference in the effects of NGF and EGF can be
ascribed to a quantitative rather than qualitative difference in
the induction of the mitogen-activated protein (MAP) kinase
cascade (whose activation is in itself sufficient to induce
differentiation; Refs. 28-30). Indeed, quantitative as well as
qualitative modifications might influence the effect of the
PC3 protein. In fact, we have observed in NIH3T3 and PCi 2
cells that the inhibition of proliferation correlates with the
level of expression of the P03 protein and that the state of
phosphorylation of PC3 changes in response to NGF.4 Thus,
additional studies aimed at clarifying the role of the P03
protein should analyze its antiproliferative action as a func-
tion of the length of time of its expression, the cell cycle
phase at which it occurs, and specific posttranslational mod-
ifications. Such analysis should also be performed for the
induction of P03 protein expression by EGF in P0i2 cells,
which is about one-fourth of that by NGF5 (i 2).
Antiproliferative Action of PC3. The demonstration of an
antiproliferative action of P03 raises a compelling question
about its physiological role. Cell growth inhibition by P03
could be a signal for a temporary or definitive exit from the
cell cycle, possibly acting as a prerequisite for other cellular
states (e.g., in P012 cells, the NGF-dependent neuronal
differentiation). Of note, the recently identified protein Tob
(Mr about 45,000) presents homology in its amino-terminal
half to PC3 and displays antiproliferative activity in NIH3T3
cells. The carboxyl-terminal half of Tob directly interacts with
p1 85erbB-2 (the product of the gene c-erb-2, a member of the
EGF receptor family), and it has been proposed that Tob can
act as a negative modulator of the proliferative signal trig-
gered by pi 85erbB-2 (i 6). We have not yet identified the P03
target molecules. However, that observation, together with
our data, raises the possibility of a general effect of P03 on
cell cycle linked to the signal transduction cascade of factors
negatively or positively regulating cellular proliferation. This
would be in line with the fact mentioned above that P03 is
induced not only by the proliferation inhibitor NGF but also
by proliferative stimuli. In PCi 2 cells, exogenous overexpres-
sion of P03 inhibits proliferation, as seen by the colony
formation assay, but does not elicit differentiation in the
absence of NGF.6 This would indicate that P03 is not suffi-
cient to induce differentiation and that additional cellular
signals are required to effect differentiation. Furthermore, the
transient induction of P03 by NGF in PCi2 cells closely
resembles the transient pattern of induction seen in vivo
during neurogenesis, in which the expression of P03 is lim-
ited to the moment of transition from the proliferating neu-
roblast to the postmitotic neuron (i4). The present data are
compatible with our previous hypothesis that P03 might be
a physiological effector of the growth arrest induced by
developmentally regulated cellular cues in the neuroblast
(i 4). However, neither NIH3T3 cells growth-arrested by se-
rum starvation, the postmitotic neuron in the mantle zone of
the neural tube, nor the neuronally differentiated chromaffin
cell express P03 (Ref. i 4; data not shown). This indicates
that in physiological conditions, P03 is not associated with
permanent growth arrest. Thus, if in vivo P03 leads the cell
to growth arrest, such a role, being effective only within a
very short period, is preliminary to other signals downstream
locking the cell in a permanent G0 state.
Possible Mechanisms of PC3 Action. One of these sig-
nals might be pRB, a key growth-suppressor protein (re-
viewed in Refs. 3i , 32, and 24). This protein regulates the
cycle in most cell types (including the neuron cell, Ref. 33).
Overexpression or hypophosphorylation of pRB inhibits pro-
gression into S phase; conversely, all the conditions deter-
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Fig. 6. Cell cycle progression
after serum stimulation of G0-ar-
rested NIH3T3 clones overex-
pressing PC3. Clones Si , S4,
and V2 were rendered quiescent
by serum starvation and then
stimulated to reenter the cell cy-
cle. The percentages of cells in
GO/Gi, S and G2-M phase for
each cell line at various times af-
ter serum stimulation were calcu-
lated from flow cytometric meas-
urements of DNA contents during
the ensuing cycle. values are the
means  SEM of three experi-
ments. *, P < 0.05 versus the
corresponding value of the V2
clone; **, P < 0.01 versus the
corresponding value of the V2
clone (Student’s paired t test).
Parental cells did not behave dif-
ferently than the V2 clone in-
fected with the virus without a
PC3 insert.
-1 16
Fig. 7. lmmunoblot analysis of the relative abundance of pRB isoforms in NIH3T3 clones overexpressing PC3. Clones stably infected with the virus either
carrying PC3 (Si and S4) or not (Vi and V2) were grown in 10% FCS. Parental cells were either grown in 10% FCS (NIH3T3+) or subsequently shifted to
0.5% FCS (NIH3T3-). Equal numbers of cells (4 x i0) were seeded into 90-mm culture plates. Clones were harvested at the indicated time points after
plating, while parental cells were harvested after 2 days (NIH3T3+) or after 3 days plus an additional 72 h of exposure to 0.5% FCS, i.e. , when confluence
had been attained (NIH3T3-). Fifty g of whole cell extract protein were loaded on an SDS/7% polyacrylamide gel and blotted and incubated with G3-245
anti-pRB monoclonal antibody (0.5 pg/mI; PharMingen), followed by chemiluminescent assay. Multiplets (slower migrating bands) represent the hyper-
phosphorylated forms of pRB (phos). Cell densities at the different time points, calculated from cultures grown in parallel, were as follows (indicated as mean
value for each pair of clones, cells/cm2). Day i: V1N2, 7.8 x i03; Si/S4, 7.7 x i03; day 3: viN2, 20 x i03; Si/S4, i4 x i03; day 5: ifV2, 70 x i03;
Si/S4, 29 x i03.
mining pRB phosphorylation lead to cell proliferation (see
Ref. 3i). Thus, the control exerted by pRB on G1 progres-
sion, by regulating the activity of genes responsible for the
advancement of the cell through the initial phase of the cycle,
is a function of the state of phosphorylation of pRB. In
P03-expressing NIH3T3 cultures, the pRB singlet species of
Mr 1 05,000 corresponding to the hypophosphorylated (thus
active) isoform becomes predominant at a cell density largely
permissive for growth, whereas in control clones, the species
corresponding to hyperphosphorylated pRB are still de-
tected at an even higher density. This is consistent with the
condition of growth inhibition observed in P03-expressing
cells. Certainly, based on these data, it is not yet possible to
define whether in NIH3T3 cells expressing P03 the earlier
appearance of the active form of pRB, responsible for growth
inhibition, is directly regulated by P03 or not. Of note, it has
been recently found that NGF represses pRB phosphoryla-
tion in P0i2 cells, possibly by inhibition of the specific cy-
din-dependent kinases responsible for pRB phosphoryla-
tion, indicating that these events are of central importance in
the NGF-mediated block of cell cycling (34, 35). Thus, further
work is necessary to ascertain the molecular mechanism by
which P03 influences pRB in NIH3T3 cells and whether
these findings can be extended to the NGF-activated ma-
chinery in P012 cells.
Materials and Methods
Cell Culture. NIH3T3 cells were cultured in DMEM containing iO% FCS
(Hyclone Laboratories, Logan, UT) in a humidified atmosphere of 5% CO2
at 37#{176}C.PCi2 cells were grown in DMEM containing 5% bovine serum
and 5% horse serum (Hyclone Laboratories) in 1 0% CO2. Synchronization
was obtained by serum starvation for 72 h, i.e. , for NIH3T3 cells in DMEM
1334 Inhibition of Proliferation by the PC3 Gene
7 A. Montagnoli and F. Tirone, unpublished data.
with 0.5% FCS and PC12 cells in DMEM without serum, according to
procedures described by Rudkin et a!. (1 0) and Rouaft et a!. (1 5). Medium
exchange was preceded by three washes of cell cultures in serum-free
DMEM.
Production of Anti-PC3 Polyclonal Antibody. A male New Zealand
White rabbit (Gennari, Rome, Italy) was immunized with the entire PC3
protein (1 58 amino acids long; Ref. 1 2) fused at the NH2-terminal with a
Histidmne-tagged peptide. The fusion protein was produced by expressing
in Escherichia colithe vector pRSETA(Invitrogen, San Diego, CA) in which
had been cloned the coding region of PC3 cDNA (nucleotides 6-41,
with the stop codon), amplified by PCR using primers that incorporated 5’
XhoI and 3’ EcoRl sites and confirmed by sequencing. Bacteria were
induced to express the fusion protein by the addition of 2 m isopropyl
/3-thiogalactopyranoside. The protein was affinity-purified from inclusion
bodies under denaturing conditions using a column of Ni2-charged
Sepharose resin according to the manufacturer’s instructions (Invitrogen),
refolded from 8 M urea by dialysis against PBS, and concentrated with a
Centricon 3 ultrafilter (Arnicon, Danvers, MA). SDS-PAGE visualized a
single band. Purified fusion protein (0.5 mg) was emulsified with an equal
volume of complete Freund’s adjuvant for the first injection and incorn-
plete Freund’s adjuvant for booster injections for a total of three injections
every three weeks followed by monthly booster injections. The immune
serum was then purified by affinity chromatography, the first time through
a column of cyanogen bromide-activated Sepharose 4B resin (Pharmacia,
Uppsala, Sweden) conjugated to a fusion protein of polyhistidine with the
extracellular domain of the TrkB receptor protein (to subtract lgGs di-
rected against the polyhistidine peptide); thereafter, the eluted volume
was loaded through another column of cyanogen bromide-activated
Sepharose 4B resin conjugated to the PC3 fusion protein. The buffer of
the flow through was exchanged with PBS, and the antibody was con-
centrated with a Centricon 3 ultrafllter. This affinity-purified antibody,
called A3H, was used in all the procedures for PC3 protein detection. The
specificity of A3H was verified by size comparison of immunoprecipitates
of the PC3 protein either in vivo from whole cell lysates of NGF-treated
PCi 2 cells or in vitro synthesized in a rabbit reticulocyte lysate system
(Promega, Madison, WI).
Detection of PC3 ProteIn In Vitro and In Vivo. The full-length PC3
protein was produced in vitro using a capped mRNA template synthesized
by T3 RNA polyrnerase from a pBluescript KS vector in which the corn-
plete cDNA sequence of PC3 (see Ref. 12) had been cloned by us in the
Clal-Xbal sites.7 The synthetic RNA was translated using a nuclease-
treated rabbit reticulocyte lysate (Promega) in the presence of Pro-mix35S
(Arnersharn, Little Chalfont, United Kingdom)to afinalconcentration of 0.8
mCVmI [5S]methionine. Immunoprecipitation of the in vitro PC3 protein
was performed using a described procedure (36). Briefly, the protein was
denatured in 4% v/v (final concentration) SOS followed by heating in
boiling water. The sample was precleared with pre-immune rabbit serum
and immunoprecipitated with immune serum in the presence of 1 50 m
NaCI, S mM EDTA, 40 mM Tris-HCI (pH 7.4), 0.4% SDS, 1 % Triton X-100,
and Sepharose-protein A CL-4B (Pharmacia) as immunoadsorbent at 4#{176}C
for 3 h. The immune complexes were pelleted by centrifugation (5 mm at
200 x g at 4#{176}C),washed three times in immunoprecipitation buffer with
140 m NaCI, and washed once in immunoprecipitation buffer without
NaCI.
In PC12 and NIH3T3 cells, the PC3 protein was immunoprecipitated
from cultures (about 1 x 106 cells onto 35-mm plates) preincubated in
medium without methionine for an hour, then labeled by incubation in
medium containing Pro-rnix35S (0.1 mCVmI [5S]methionmne) added 90
mm before harvesting. In PC12 cells, exposure to NGF (100 ng/ml) before
harvesting was for the time lengths indicated. Lysis and immunoprecipi-
tation were essentially as described (37). Cells were incubated for 30 mm
at 4#{176}Cin ice-cold lysis buffer [SO m Tris-HCI (pH 7.5), 1 m,.i EDTA, and
iso m NaCI] containing 1% NP4O, S pg/mI leupeptin, S g/ml aprotinin,
and i m phenylmethylsulfonyl fluoride. The sample was then precleared
for 1 h at 4#{176}Cand immunoprecipitated for 2 h at 4#{176}Cin lysis buffer, and
the immunocomplexes were washed three times in lysis buffer. In the
immunoprecipitation procedures, no appreciable difference was observed
between A3H anti-PC3 antibody and crude immune serum. lmmunofluo-
rescence staining of the PC3 protein in NIH3T3 cells was performed after
the procedure described previously (38). Briefly, cells were fixed with
3.75% paraformaldehyde in PBS for iO mm at room temperature, per-
meabilized with 0.2% Triton in 0.1 M Tris-HCI (pH 7.5) for 5 mm at room
temperature, and incubated with A3H and then with the secondary anti-
body.
Infection of NIH3T3 Cells. The retroviral vector used was pBABE
Nec, a Moloney murine leukemia virus-based vector carrying the neomy-
cm resistance gene nec (39). In the BamHI site of the pBABE Neo poly-
linker, a HincII-Dral fragment of PC3 cDNA containing the entire coding
region was cloned by addition of nonphosphorylated BamHl linkers. The
pBABE Neo-PC3 construct as well as the pBABE Nec vector without
insert was transfected by conventional calcium phosphate procedures
(40) into the helper-free ecotropic packaging cell line  (grown in DMEM
with 10% FCS; Ref. 41). Stably infected virus-producing )i2 cells were
then obtained by selecting the transfected )i2 cultures in G4i8 (0.5 mg/
ml). The virus was obtained by allowing the resistant clones to reach
confluence, replacing the medium, and harvesting the virus-containing
conditioned medium after 24 h. The latter medium was then filtered with
a 0.45-p.m filter and frozen in liquid N2. The virus titer was >1 05/ml. This
virus-containing medium, diluted to different extents (1:10 or 1:100) in
medium and supplemented with polybrene (8 mg/mI), was added to
NIH3T3 cultures (2 mVi0O-mm plate) for 2 h. Fresh medium was then
added, and after 48 h, the cultures were split 1 :20 into selection medium
(with 0.5 mg/mI G4i 8). Several resistant clones were isolated from cul-
tures infected with the virus either carrying or not carrying the PC3
sequence. The former were analyzed for PC3 expression by RT-PCR
assay.
Cell Counts. The number of viable cells was determined as described
by Soto and Sonneschein (42). The nuclei of viable cells are cleariy
visualized as phase-bright circles surrounded by a dark ring, whereas
those of dying cells are opaque and smaller (see Refs. 43 and 44). Cell
counts of samples analyzed in parallel by this method and by trypan blue
dye exclusion presented equivalent values, within the experimental error.
Briefly, to measure floating cells, the culture medium was removed, cen-
tnfuged, and decanted, and the resulting pellet was lysed with 0.5%
ethylhexadecyldimethylammonium bromide, 0.28% acetic acid, 0.5% Tri-
ton X-iOO, 3 mM NaCI, and 2 m MgCl2 in PBS (pH 7.4) diluted 1:10. The
same lysate was then applied to the corresponding cell plate, and after 2
mm, the suspension was collected, and intact nuclei were counted. This
procedure allowed us to count viable adherent and floating cells.
Morphological Evaluation of Apoptosis. Apoptosis was evaluated
by analysis of nuclear morphology, as described (22). Immediately after
immunofluorescence staining, samples were incubated with Hoechst dye
33258 (Sigma Chemical Co.; 8 mg/mI) for 5 mm, washed, and mounted
with PBS:glycerol (3:1).
BIdU Incorporation. DNA synthesis assay was performed as de-
scribed (45). Cells were incubated for 18 h in culture medium containing
so m BrdU and fixed thereafter in 3.7% paraformaldehyde in PBS. DNA
was partially denatured by a iO-s incubation in 50 mti NaOH followed by
three washes in PBS. The incorporated BrdU was then revealed by an
anti-BrdU mouse monoclonal antibody (Amersham) and a FITC-conju-
gated goat anti-mouse IgG (Sigma).
Colony Formation Assay. pBABE Nec vector carrying the full-length
PC3 coding region in both sense (pBABE Neo-PC3; see above) and
antisense (PBABE Neo-PC3AS) orientations or without the insert was
transfected into NIH3T3 and PC12 cultures as described (23). Addition-
ally, a pBABE Nec vector carrying a PC3 insert with a nonsense mutation
in the ATG codon (pBABE Neo-PC3/P-) was transfected in NIH3T3 cells.
pBABE Neo-PC3/P- was produced by cloning the coding region of PC3
cDNA, corresponding to the HincII-DraI fragment of PC3 cDNA amplified
by PCR using primers incorporating 5’ EcoRI and 3’ SaIl sites and carrying
a mutated ATG codon (TAG), into pBABE Nec (EcoRI-Sall sites). An equal
number of cells were plated into 60-mm plates 1 6-20 h before transfec-
tion (performed at 25-60% confluence). Transfections of the plasmids
pBABE Neo-PC3, pBABE Nec, and pBABE Neo-PC3AS were performed
by either liposomes for PC12 cells (Lipofectammne Reagent; Life Technol-
ogies, Inc., Gaithersburg, MD; 3 g DNA/plate), after the procedure de-
scribed by the producer, or calcium phosphate (5 tg DNA/plate; Ref. 40)
for NIH3T3 cells. After 48 h, the cultures were split into a 90-mm plate at
serial dilutions and grown in medium containing G4i8 (0.5 mg/mI for
NIH3T3 and 0.8 mg/mI for PCi2 cells) to allow resistant cells to form
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colonies. These were usually obtained in 2-3 weeks for NIH3T3 cells or 7
weeks for PCi 2 cells. The cutoff point for colony size was >20 cells/
colony.
Flow Cytometry Analysis. For DNA content measurements, cells
were trypsinized, pelleted by centrifugation, resuspended In PBS, further
dissociated by 10 passages through a syringe with a 22-gauge needle,
and fixed immediately thereafter in ethanol (70% final concentration).
Fixed cells were then stained with propidium iodide (50 gig/mI) in PBS
containing RNase A (Sigma Chemical Co., 100 kilounits/mI). The fluores-
cence was measured by an EPICS 541 flow cytometer (Coulter Electron-
ics Inc.), exciting the fluorescence with the 488-nm line of an Argon-ion
laser Innova 90 (Coherent) emitting a power of 50 mW and collecting the
fluorescence after a 590-nm long-pass filter. DNA histograms were ana-
lyzed by a suitable mathematical model (46).
Preparation of RNA. Total cellular RNA used for Northern analysis
and RT-PCR assay was obtained from cell cultures by homogenization in
4 M guanidine thiocyanate followed by extraction with phenol-chloroform
(47). RNA for Northern analysis was separated electrophoretically, trans-
ferred to nitrocellulose filters, and hybridized as described (38) to a PC3
PstI-PstI i .5-kb fragment excised from the pUC9-PC3 vector (12) and a
mouse histone H4 cDNA fragment (48) labeled with the hexamer primers
procedure (49). RNA was checked by hybridizing the filters to the glycer-
aldehyde-3-phosphate dehydrogenase cDNA. RNA for RT-PCR assay
was digested before cDNA synthesis in RNase-free DNase (Promega;
1000 units/mI) for 30 mm at 37#{176}C.
RT-PCR Assay. Total cellular RNA (10 g) was denatured at 75#{176}Cfor
5 mm and added to a total reaction volume of 50 A1 containing 1 X AT
buffer [10 mM Tris-HCI (pH 8.8), 50 m KCI, and 0.1 % Triton X-100], S m
MgCl2, 0.5 M of each deoxynucleotide triphosphate, i unit of RNAsin
(Promega), and 600 pmol of random hexamer primers. Moloney murine
leukemia virus AT (200 units; Promega) was added to half the reaction
volume (25 Al) and incubated for 2 h at 37#{176}C(the remaining reaction
volume without AT was kept for use in PCR amplifications as a control for
possible contamination of the sample with genomic DNA). AT reactions
were stored at -20#{176}Cand then used for PCR amplification of specific
samples. Two A’ of each AT reaction were then amplified in a 100-id PCR
reaction containing i x PCR buffer[1O m,i Tris-HCI(pH 9 at 25#{176}C),50 m
KCI, and 0.1% Triton X-iOO], 0.2 m of each deoxynucleotide triphos-
phate, 1 .5 mM MgCI2, 20 pmol of each primer, and 2 units of Taq polym-
erase (Prornega) after covering with 50 d of mineral oil. Amplifications
were carried out in an automated DNA thermal cycler (M. J. Research,
Inc.) with the following profile: denaturation at 94#{176}Cfor 60 s, primer
annealing at 48#{176}Cfor 60 s, and primer extension at 72#{176}Cfor 90 s. The
number of cycles was designed to maintain the reactions of amplification
in exponential phase. This was determined to correspond to 30 cycles for
the reactions with primer pairs specifying the PC3 sequence and to 20
cycles for the reaction with -actin primer pairs, which were added after
10 cycles to each sample. Coamplification of -actin mRNA gave a
measure of the efficiency of the reaction and the starting RNA amount in
each sample because (3-actin is constitutively expressed in the cell lines
used. One-tenth of the PCR sample was electrophoresed on 1.2% aga-
rose gel, blotted on nylon filter, and hybridized to specific 32P-labeled
probes. These were the 1 .5-kb PstI-Pstl fragment of PC3 excised from the
pUC9-PC3 vector (12) and a mouse 3-actin cDNA fragment. The relative
product amounts were quantitated by analysis with a Molecular Dynamics
400A Phosphorimager system. The PCR primers used were: (a) PC3, 5’
[5’-ATGAGCCACGGGAAGAGA-3’] and 3’ [5’-GTCGACCACTGTGCTGG-
3’] (the latter primer is reverse complementary to the pBABE poly-lmnker In
the 3’ region of the cloning site of PC3, thus the PC3-amplified product
derives only from the PC3 exogenous viral transcript); and (b) cytoplasmic
f3-actin, [5’-1TGAGACC1TCAACACCC-3’] and 3’ [5’-GCAGCTCAT-
AGCTCUCT-3’] (50).
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